Quarterly report pursuant to Section 13 or 15(d)

CONDENSED STATEMENTS OF CASH FLOWS (Unaudited)

v3.23.3
CONDENSED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Cash flows from operating activities:    
Net loss $ (3,599) $ (7,640)
Adjustments to reconcile net loss to net cash used in operating activities:    
Gain on sale of assets (1,732)
Depreciation and amortization 109 151
Stock-based milestone payment 50
Stock-based compensation 965 1,038
Other (1) 2
Changes in operating assets and liabilities:    
Receivables 63
Inventory (167)
Prepaid expenses and other assets 122 (34)
Accounts payable (374) (182)
Deferred grant revenue (184) (34)
Other accrued liabilities (152) 149
Net cash used in operating activities (4,846) (6,604)
Cash flows from investing activities:    
Proceeds from sale of assets 228
Net cash provided by investing activities 228
Cash flows from financing activities:    
Net proceeds from equity offering 4,980
Net proceeds from issuance of preferred stock 9,094
Proceeds from short-term loans 750
Net proceeds from the exercises of common stock warrants 4
Payments on short-term loans (250)
Net cash provided by financing activities 9,594 4,984
Net increase (decrease) in cash, cash equivalents and restricted cash 4,976 (1,620)
Cash, cash equivalents and restricted cash at beginning of period 3,133 6,332
Cash, cash equivalents and restricted cash at end of period 8,109 4,712
Supplemental cash flow information:    
Interest paid 4
Inventory transferred with sale of assets 106
Property and equipment, net, transferred with sale of assets 109
Notes receivable received in connection with sale of assets 1,500
Accounts payable related to sale of assets 17
Other accrued liabilities transferred with sale of assets 236
Cash and cash equivalents 8,096 4,450
Restricted cash 13 262
Cash, cash equivalents and restricted cash shown in the condensed statements of cash flows $ 8,109 $ 4,712